Resources
Showing 16 of 75 results
Congress Session
Poster session (1)
19 June 2026
Congress Session
From clone control to fibril clearance: an amyloidosis update for daily practice
19 June 2026
Congress Session
Cardio-onco pharmacology: expanding the multidisciplinary team and facing new challenges
19 June 2026
Congress Session
Which is the best model to study cancer treatment-related cardiovascular toxicity?
19 June 2026
Congress Session
Tackling challenging problems with expert answers
19 June 2026
Congress Session
Clinical challenges in cardio-oncology: thrombosis, sudden death and pulmonary hypertension
19 June 2026
Congress Session
Cardiocare: AI-enabled cardio-oncology pathway across ages
19 June 2026
Congress Session
Stratifying the risk of cardiotoxicity
19 June 2026
Congress Session
Preventing cardiotoxicity
19 June 2026
Congress Session
From exposure to events: cardiovascular risk in cancer care
19 June 2026
Congress Session
Early signals, real prevention: AI, imaging and cardioprotection in cardio-oncology
19 June 2026
Congress Session
Diagnostic uncertainties and the role of multimodality imaging
19 June 2026
Congress Session
Translational frontiers in cardio-oncology
19 June 2026
Congress Session
The floor is yours – bring your questions on risk stratification in cardio-oncology: what works and what does not
19 June 2026
Congress Session
Stratifying the risk of cardiotoxicity (1)
19 June 2026
Congress Session
Immune checkpoint inhibitors and the many faces of cardiac injury: from myocarditis to coronary and conduction disease
19 June 2026


